Delivery Order SPE2DB22D2206-SPE2DB24FGT48
- Not listed
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, Corporate Office Division, a firm-fixed-price delivery order contract valued at $1,286.16 for the supply of 4,565,784,148 glimepiride 4 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products to the U.S. federal government. This delivery order is part of the company's broader...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Glimepiride 4 mg tablets. The $1,872.20 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,451.03 firm fixed price delivery order is for the supply of 4564000979 - GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024 and does not have any set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,934.86 firm fixed-price contract is for the delivery of 4,565,910,408 units of the prescription drug Glimepiride 4 mg tablets. This contract is not set aside for any special designation. Amerisourcebergen has extensive federal contracting experience, holding several Indefinite Delivery Contracts (IDCs) with agencies like the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major command within the U.S. Department of Defense. The contract, valued at up to $1,723.02, is for the delivery of Glimepiride 4 mg tablets. This award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 2025. The IDC serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The contract has a ceiling value of $3,339.09 and an ultimate completion date of August 19, 2024. This contract is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts, including a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. government has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Glimepiride 4 mg tablets. The contract, valued at $1,343.40, is funded by the Defense Logistics Agency (DLA), a defense agency. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of glimepiride 4 mg tablets. The contract is a delivery order with a firm fixed price of $2,283.44 and a completion date of March 12, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGT48Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4 mg Glimepiride tablets. The $1,018.49 fixed-price contract has an April 2024 completion date and is not a set-aside. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medications and medical supplies to various federal agencies, with a focus on supporting the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver pharmaceuticals and supplies to DoD facilities globally, as well as a smaller IDC with the Department of Justice Federal Bureau of Investigation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/18/24 |